A detailed history of Northwestern Mutual Wealth Management CO transactions in Cassava Sciences Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 12 shares of SAVA stock, worth $28. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$28
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$9.57 - $35.08 $114 - $420
12 New
12 $0
Q1 2024

May 15, 2024

SELL
$18.44 - $26.41 $2,673 - $3,829
-145 Reduced 67.44%
70 $1,000
Q4 2023

Feb 13, 2024

BUY
$12.64 - $30.11 $2,717 - $6,473
215 New
215 $4,000
Q4 2022

Feb 21, 2023

BUY
$27.82 - $44.16 $55 - $88
2 New
2 $0
Q2 2022

Aug 04, 2022

SELL
$17.22 - $38.47 $2,118 - $4,731
-123 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$32.6 - $53.05 $4,009 - $6,525
123 New
123 $5,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $94.2M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.